Orphan medicinal products (OMPs) authorized by the European Union (EU) benefit from market exclusivity, fee waivers, and national incentives. Maintaining orphan status during a marketing authorization

DataCite Commons2024-11-29 更新80

Product Data for Newly Reported Drugs in the Medicaid Drug Rebate Program 2024-01-22-to-2024-01-28

医疗补助药品报销

药品市场准入

The data below contains newly reported, active covered outpatient drugs which were reported by participating drug manufacturers since the last quarterly update of the Drug Products in the Medicaid Dru

Medicaid & CHIP Open Data120

Top biologic drugs by share of total drug costs in Canadian public plans 2021/2022

生物药品

公共医保支出评估

Top biologic drugs by share of total drug costs within select Canadian public drug plans in 2021/2022

Statista80